Performance of TGTX TG Therapeutics | 128.7% in 12m
Compare TGTX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare TG Therapeutics with its related Sector/Index XBI
Performance Duell TGTX vs XBI
| TimeFrame | TGTX | XBI |
|---|---|---|
| 1 Week | 8.06% | 1.00% |
| 1 Month | 12.3% | 3.39% |
| 3 Months | 38.0% | 5.72% |
| 6 Months | 46.4% | 3.10% |
| 12 Months | 128.7% | 28.65% |
| YTD | 36.1% | 9.92% |
| Rel. Perf. 1m | 0.84 | |
| Rel. Perf. 3m | 3.77 | |
| Rel. Perf. 6m | 3.66 | |
| Rel. Perf. 12m | 3.66 | |
| Spearman 1m | -0.24 | -0.17 |
| Spearman 3m | 0.81 | 0.62 |
Is TG Therapeutics a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, TG Therapeutics (NASDAQ:TGTX) is currently (September 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 79.07 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TGTX as of September 2024 is 24.54. This means that TGTX is currently overvalued and has a potential downside of 3.41% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TGTX as of September 2024 is 24.54. This means that TGTX is currently overvalued and has a potential downside of 3.41% (Sold with Premium).
Is TGTX a buy, sell or hold?
- Strong Buy: 5
- Buy: 2
- Hold: 1
- Sell: 1
- Strong Sell: 0
Values above 0%: TGTX is performing better - Values below 0%: TGTX is underperforming
Compare TGTX with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 6.34% | 7.46% | 37.53% | 101.29% |
| US NASDAQ 100 | QQQ | 5.42% | 7.46% | 39.43% | 100.20% |
| US Dow Jones Industrial 30 | DIA | 7.20% | 7.59% | 40.14% | 107.90% |
| German DAX 40 | DBXD | 8.43% | 7.84% | 43.70% | 110.43% |
| UK FTSE 100 | ISFU | 8.85% | 9.14% | 35.53% | 111.07% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 9.90% | 16.81% | 55.10% | 140.24% |
| Hongkong Hang Seng | HSI | 8.50% | 9.12% | 49.53% | 133.62% |
| Japan Nikkei 225 | EXX7 | 6.91% | 6.33% | 49.57% | 114.92% |
| India NIFTY 50 | INDA | 7.15% | 8.55% | 34.66% | 100.69% |
| Brasil Bovespa | EWZ | 10.30% | 12.81% | 53.48% | 131.62% |
TGTX TG Therapeutics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 7.50% | 10.62% | 38.46% | 99.93% |
| Consumer Discretionary | XLY | 5.90% | 2.20% | 40.53% | 116.53% |
| Consumer Staples | XLP | 7.84% | 6.47% | 35.04% | 109.61% |
| Energy | XLE | 10.34% | 17.58% | 49.16% | 133.10% |
| Financial | XLF | 9.33% | 7.08% | 36.95% | 99.09% |
| Health Care | XLV | 7.18% | 8.00% | 39.61% | 108.90% |
| Industrial | XLI | 6.42% | 7.76% | 39.94% | 103.60% |
| Materials | XLB | 7.16% | 8.11% | 43.88% | 113.99% |
| Real Estate | XLRE | 5.17% | 4.29% | 31.89% | 102.29% |
| Technology | XLK | 3.29% | 6.50% | 42.10% | 97.83% |
| Utilities | XLU | 7.00% | 7.27% | 22.34% | 105.35% |
| Aerospace & Defense | XAR | 6.95% | 8.48% | 36.36% | 97.34% |
| Biotech | XBI | 7.06% | 8.91% | 43.30% | 100.05% |
| Homebuilder | XHB | 4.85% | 4.31% | 36.17% | 80.95% |
| Retail | XRT | 8.56% | 11.38% | 48.39% | 109.05% |
Does TG Therapeutics outperform its market, is TGTX a Sector Leader?
Yes, over the last 12 months TG Therapeutics (TGTX) made 128.70%, while its related Sector, the SPDR S&P Biotech (XBI) made 28.65%.
Over the last 3 months TGTX made 37.95%, while XBI made 5.72%.
Yes, over the last 12 months TG Therapeutics (TGTX) made 128.70%, while its related Sector, the SPDR S&P Biotech (XBI) made 28.65%.
Over the last 3 months TGTX made 37.95%, while XBI made 5.72%.
| Period | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 12.30% | 3.39% | 4.84% |
| 3 Months | 37.95% | 5.72% | 3.61% |
| 12 Months | 128.70% | 28.65% | 27.41% |